Key result
The EVOLVO study is a randomized controlled trial protocol designed to evaluate whether remote monitoring reduces unplanned cardiac or device-related in-hospital visits compared to standard care in heart failure patients with implantable defibrillators.
Why the study?
Does remote ICD management using the Medtronic CareLink monitor reduce unplanned cardiac or device-related in-hospital visits in patients with heart failure and an ICD/CRT-D?
Population
200 patients with left ventricular systolic dysfunction implanted with a wireless-transmission-enabled…
Comparison
Remote ICD management using the Medtronic… vs Standard in-office follow-up visits at 4, 8, 12…
Design
RCT, 1:1 randomization, stratified by center and by time from implantation…
Follow-up
16 months
Authors
Loading...
The EVOLVO study is designed to determine if remote monitoring of ICD/CRT-D patients reduces unplanned hospital visits compared to standard in-person care.
RCT (n=200)
Open-label
1:1 stratified by center and time from implantation
Yes
Does remote ICD management using the Medtronic CareLink monitor reduce unplanned cardiac or device-related in-hospital visits in patients with heart failure and an ICD/CRT-D?
The EVOLVO study is designed to determine if remote monitoring of ICD/CRT-D patients reduces unplanned hospital visits compared to standard in-person care.
Marzegalli et al. (2009) conducted an RCT in Heart failure (n=200). Medtronic CareLink system vs. Standard in-person evaluations was evaluated on Rate of unplanned cardiac or device-related in-hospital visits. The EVOLVO study is a randomized controlled trial protocol designed to evaluate whether remote monitoring reduces unplanned cardiac or device-related in-hospital visits compared to standard care in heart failure patients with implantable defibrillators.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: